Sign in to view content

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

Chirag D. Jhaveri, MD, FASRS

Video
Published 2022

Related

Outcomes of DRCR Network Treatment Regimen Starting With Observation for Eyes With Center-involved DME and Good Visual Acuity
Omar S. Punjabi, MD
Annual Meeting Talks
2019
Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2019
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial
Andres Emanuelli, MD
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more